产品名称 | CNF 2024 - BIIB 021 |
产品货号 | Axon 1543 CAS [848695-25-0] MF C14H15ClN6OMW 318.76 Purity: 99% Soluble in DMSO Description Oral inhibitor of heat shock protein 90 (Hsp90) under clinical development References Certificates Categories Extra info B Böll et al. Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-κB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell–Mediated Cytotoxicity. Clin. Cancer Res. 2009, 15(16), 5108–16. T Taldone et al. Targeting Hsp90: small-molecule inhibitors and their clinical development. Cur. Opin. Pharmacol. 2008, 8(4), 370-374. Certificate of Analysis Material Safety Data Sheet Apoptosis Cardiovascular Cell Cycle Regulation Cell Signaling & Oncology Hsp90 EC 3.6 Hsp90 inhibitor Chemical name 6-Chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine Parent CAS No. [848695-25-0] Order Size Unit Price Stock 5 mg €80.00 In Stock |
产品价格 | 现货询价,电话:010-67529703 |
产品规格 | |
产品品牌 | axonmedchem |
产品概述 | |
产品详情 |
CNF 2024 - BIIB 021Axon 1543 CAS [848695-25-0] MF C14H15ClN6O
Description
Oral inhibitor of heat shock protein 90 (Hsp90) under clinical development
Hsp90 inhibitor
Chemical name6-Chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine Parent CAS No.[848695-25-0] |
产品资料 |